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Abstract
The human leukocyte antigen (HLA) DRB1*1501 has been consistently associated with multiple sclerosis (MS) in nearly all
populations tested. This points to a specific antigen presentation as the pathogenic mechanism though this does not fully
explain the disease association. The identification of expression quantitative trait loci (eQTL) for genes in the HLA locus
poses the question of the role of gene expression in MS susceptibility. We analyzed the eQTLs in the HLA region with
respect to MS-associated HLA-variants obtained from genome-wide association studies (GWAS). We found that the Tag of
DRB1*1501, rs3135388 A allele, correlated with high expression of DRB1, DRB5 and DQB1 genes in a Caucasian population. In
quantitative terms, the MS-risk AA genotype carriers of rs3135388 were associated with 15.7-, 5.2- and 8.3-fold higher
expression of DQB1, DRB5 and DRB1, respectively, than the non-risk GG carriers. The haplotype analysis of expression-
associated variants in a Spanish MS cohort revealed that high expression of DRB1 and DQB1 alone did not contribute to the
disease. However, in Caucasian, Asian and African American populations, the DRB1*1501 allele was always highly expressed.
In other immune related diseases such as type 1 diabetes, inflammatory bowel disease, ulcerative colitis, asthma and IgA
deficiency, the best GWAS-associated HLA SNPs were also eQTLs for different HLA Class II genes. Our data suggest that the
DR/DQ expression levels, together with specific structural properties of alleles, seem to be the causal effect in MS and in
other immunopathologies rather than specific antigen presentation alone.
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Introduction
Multiple sclerosis (MS) is a common inflammatory disorder of
the central nervous system characterized by demyelination with
axonal and neuronal degeneration [1]. The cause of MS is
unknown; however, susceptibility to MS is thought to be conferred
by a combination of genetic and environmental factors [2].
The human leukocyte antigen (HLA) exerts the largest genetic
contribution to MS susceptibility but exactly how it alters the risk
of developing MS is not yet fully understood [3,4]. Association
studies based first on serological typing and more recently on
genome-wide association studies (GWAS) have been conducted for
MS and other autoimmune diseases, and have identified specific
HLA-DR/DQ genes. However, the remarkably strong linkage
disequilibrium (LD) across the HLA region has hampered the
unequivocal ascertainment of the primary disease-risk HLA gene.
This Class II association has been mapped to the DRB5*0101-
DRB1*1501-DQA1*0102- DQB1*0602 haplotype in the North
European population [5]. These alleles are almost always present
together in this population, making it impossible to distinguish the
primary association. The mechanism for the strong LD in these
HLA haplotypes has been shown to be consistent with a functional
epistatic interaction between DRB1*1501 and DRB5*0101 alleles.
This functional epistasis is associated with a milder form of
experimental autoimmune encephalomyelitis (EAE) in mice [6].
On the other hand, association studies in African-American
populations have suggested that the DRB1*1501 allele itself
determines MS-associated susceptibility [7]. However, in other
populations, the risk allele or haplotype is different or does not
contain DRB1*1501 as in Sardinians where MS is associated with
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the DRB1*0301–DQA1*0501–DQB1*0201 and DRB1*0405–
DQA1*0501–DQB1*0301 haplotypes [8], or in African–Brazilian
MS patients where the strongest association was observed with
DQB1*0602 rather than DRB1*1501 [9]. In Caucasians, hetero-
geneity at the DRB1 locus has also been found with respect to MS
risk [10]. In Canadian MS families it has been observed that some
DRB1*1501 haplotypes determine susceptibility while others do
not [11] and that DRB1, DQA1 and DQB1 alleles contribute to MS
susceptibility through epistatic interactions suggesting haplotypic
rather than allelic HLA association [12].
As DRB1 alleles have different structural properties for antigen
presentation according to their amino acid sequence, MS-HLA
association has been used to support the concept that disease
pathogenesis is the result of an autoimmune reaction, perhaps
against myelin-related antigens in the restricting context of
DRB1*1501 [13]. However, this structural theory alone does not
fully explain the association study results in MS. The description of
polymorphisms that alter HLA gene expression [14], identification
of several cis-acting genetic variants on expression of HLA class II
genes [15,16] as well as the recent observation that vitamin D may
influence DRB1*1501 expression via a vitamin D response element
[17], makes it possible that association of HLA class II
polymorphisms with MS may be related to the levels of gene
expression to the same or a greater extent than restriction of
antigen response.
Variation in gene transcription is important in mediating
disease susceptibility. Gene transcript abundance might be
modified by polymorphisms in regulatory elements. In particular,
much of the variation in gene expression levels and alternative
splicing can be inherited [18,19]. Polymorphisms that affect the
expression levels of a gene are most often found near the gene
itself, especially near the transcription start site [20,21]. In most
studies of gene expression genetics, generally diverse individuals
are genotyped at genetic markers that characterize most of the
common DNA variants in the population and are also phenotyped
by measuring the abundance of mRNA transcripts by microarrays
and more recently RNA sequencing (RNA-Seq) [22–25]. These
molecular phenotypes are then genetically mapped like any other
quantitative trait, revealing quantitative trait loci (QTL). Most
studies of gene expression have classified expression variations into
cis- or trans-acting factors, according to the proximity of the
variant to the gene.
The cell lines genotyped by the international HapMap
Consortium represent an ideal resource for expression QTLs
(eQTLs) analysis. These lymphoblastoid B-cell lines, representing
11 human populations have been genotyped with approximately 4
million SNPs for CEU (Caucasian), YRI (Black Africans), CHB
(Han Chinese) and JPT (Japanese) populations and with 1.5
million SNPs for other populations as part of the third phase of the
HapMap project [26]. These cell lines from seven populations
have been used to study variation in gene expression levels by
microarray [20,21] and cell lines from YRI and CEU by RNA-
Seq [24,25].
Here we integrate genotypes of the HLA polymorphisms and
expression data for the DRB5, DRB1 and DQB1 genes in relation
to the MS-GWAS associated variants to determine the role of the
SNPs that alter the expression of these genes in MS susceptibility.
Results
The same SNPs correlated with expression levels of DRB1
gene in seven different human populations
We explored the association in cis of the HLA region SNPs from
HapMap and DRB1 gene expression in different human
populations. We analyzed ILMN_1715169 (DRB1) probe data
from array quantification (Illumina Human-6 v2 Expression
BeadChip) using RNA samples from 689 lymphoblastoid cell
lines from 7 HapMap III populations: 80 from Han Chinese in
Beijing, China (CHB), 82 from Gujarati Indians in Houston,
Texas (GIH), 82 from Japanese in Tokyo, Japan (JPT), 83 from
Luhya in Webuye, Kenya (LWK), 45 from individuals of Mexican
ancestry in Los Angeles (MEX), 108 from Yoruban in Ibadan,
Nigeria (YRI) and 109 from Utah residents with Northern and
Western European ancestry from the CEPH collection (CEU).
These cell lines have been extensively genotyped by the HapMap
project, and we used the genotype data for the HLA region from
positions 29677984 to 33485635 of chromosome 6 (Build 36). The
number of genotyped SNPs in this region is 11564 for CEU,
11278 for YRI, 11564 for CHB, 11448 for JPT, 5703 for MEX,
5880 for LWK and 5650 for GIH.
Spearman rank correlation (SRC) test for association between
SNP genotypes and mRNA levels were performed as previously
described [27] (Figure 1). Significant thresholds for each
population were assigned through 10,000 permutations of
expression values (Table S1). At the 0.0001 permutation threshold
(PT), we discovered 21 CEU, 6 CHB, 33 GIH, 40 LWK, 7 MEX,
7 JPT and 14 YRI SNPs that were significantly cis-associated with
DRB1 expression. We observed that the most significant
correlations corresponded to the same 6 SNPs in all human
populations. Four SNPs were located upstream and 2 downstream
of the DRB1 gene (Figure 2). These 6 SNPs were in high LD in all
the analyzed populations (r2 = 120.95). The minor allele
frequency of these variants was similar in all populations, ranging
from 0.31 in the CEU population to 0.17 the CHB population.
After plotting the normalized expression of the DRB1 gene by
the genotypes of one of the 6 DRB1-expression associated SNPs
(rs9271100), we observed a dominant effect of the T allele since
individuals that carried TT or CT genotypes showed 1.6-fold
higher expression (Figure 3 A). Almost no difference was observed
between carrying 1 or 2 copies of the high expression allele. To
confirm these data and rule out a possible artifact of the
microarray technique, we plotted the expression data for the
DRB1 gene obtained from RNA-Seq of 41 CEU individuals [19]
against the rs9271100 genotypes (Figure 3B). We observed, as with
the microarray data, that the CC carriers express less DRB1
mRNA than the CT and TT, but in this case the differences were
larger, with a 3.3-fold increase on comparing CC with CT, and a
1.6- fold increase for TT with respect to CT, more consistent with
an additive than dominant effect. The differences observed
between both techniques could be due to an artifact, such as the
signal for the CT and TT transcripts being above the signal
saturation point of arrays.
We ruled out that the expression level differences described here
were the product of the Epstein-Barr virus-cell line-immortalization
since SNPs in LD with the ones described in this work have been
reported as eQTLs of DRB1, DRB5 and DQB1 genes in RNA
samples from postmortem liver tissues and liver surgical resections
and monocytes [15,28].
The eQTLs for DRB1 associated with MS susceptibility
Since DRB1 gene is considered the primary association with MS
in the HLA class II region, we evaluated whether the variants
associated with the changes in mRNA levels of this gene were
associated with MS susceptibility. We analyzed the data from the
International Multiple Sclerosis Genetic Consortium (IMSGC)
GWAS from 931 trios of Caucasian origin [29]. The GWAS
analyzed 779 SNPs in the HLA region from 29671046 to
33473618 (build 36) positions of chromosome 6. The 779 SNPs
High Expression of HLA Genes in MS
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Figure 1. Association of HapMap III SNPs from the HLA region with expression levels of the HLA DRB1 gene. The figure shows the
strength of association between SNPs and gene expression levels, plotted as2log P-values. Coordinates are in NCBI Build 36. Shown are the CEU, YRI,
LWK, MEX, GHI, CHB and JPT HapMap populations [26].
doi:10.1371/journal.pone.0029819.g001
Figure 2. Location of SNPs associated with DRB1 gene expression in the different human populations. Image from the UCSC browser
showing the HLA Class II region. Vertical bars indicate the location of eQTLs (0.0001 permutation threshold) from all populations. Vertical red bars
indicate the common eQTLs among all populations studied.
doi:10.1371/journal.pone.0029819.g002
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do not include the 6 main eQTLs for DRB1. After crossing the
eQTLs with the GWAS variants we observed an overlap of 3
SNPs between both lists. The following SNPs were the most
strongly associated with MS in the GWAS: rs3129900 (P = 2.63E-
34, OR 2.8, (2.3830–3.3350)), rs3129934 (P = 2.60E-37, OR 2.9
(2.4462–3.4048)) and rs9270986 (P = 2.38E-36, OR 3 (2.4938–
3.5273)). These three SNPs were in high LD (r2 = 0.7720.58) with
the most significant eQTLs of DRB1 gene. We also analyzed the
most associated polymorphisms from the HLA region in other MS
GWAS. For instance, the rs9271366 showed maximal association
in two GWAS performed on Australia-New Zealand and
Sardinian populations [30,31]. This SNP is also an eQTL for
DRB1 gene.
The most strongly associated MS variants were eQTLs for
DRB5, DRB1 and DQB1 in the Caucasian population
We decided to analyze the eQTLs for other HLA genes with
respect to MS association. For this purpose we used the eQTLs
data generated by Mongomery et al. [24] by SRC testing for
association between gene expression levels measured by RNA-Seq
from 60 CEU HapMap samples with 1.2 million HapMap III
SNPs. At 0.001 PT there were 11 genes with significant cis
association, 4 HLA Class I HLA-A, HLA-C, HLA-F, HLA-L and 7
Class II DRA, DRB5, DRB1, DQA1, DQB1, DQA2, DPB1. We
analyzed the overlap between the eQTLs of this region and the
variants associated with MS by the IMSGC GWAS [29]. After
crossing data from the IMSGC-GWAS and eQTLs, we obtained
41 eQTLs corresponding to 20 SNPs that were associated with
MS with a P value,10-7. These were eQTLs for 6 genes, 1 HLA
Class I, HLA-C, and 5 for HLA Class II, DRA, DRB5, DRB1,
DQA1, DQB1. The most strongly MS-associated SNPs were
eQTLs for DRB5, DRB1 and DQB1 simultaneously. This is due to
the strong LD of the MS most associated variants with the eQTLs
for the HLA genes. The rs3135388 SNP, tag for DRB1*1501 [32],
the most associated variant with MS in the Caucasian population,
was among the SNPs most associated with mRNA levels of DRB5,
DRB1 and DQB1 simultaneously. We plotted the expression of
these three genes, obtained from RNA-seq of 41 CEU individuals
[19], with respect to the rs3135388 genotypes showing that the AA
genotype, which is more frequent in the MS patients, correlated
with higher expression of the three genes (Figure 4A). The
homozygotic carrier for rs3135388 risk allele AA showed 15.7-,
5.2-, and 8.3-fold higher expression with respect to the GG carrier,
and 1.6-, 1.5- and 1.8- fold higher expression with respect to the
AG carrier for the DQB1, DRB5 and DRB1 genes, respectively.
To determine whether high expression of these three genes was
associated with MS we genotyped the SNPs that best correlated
with its expression in our MS Spanish cohort. These were
rs9270986 for DRB5 and rs9272346 for DQB1. The conditional
logistic regression analysis with respect to the DRB1*1501 tag
revealed that none of the variants contributed to the disease
(Table 1). The haplotype formed by the alleles associated with high
levels of expression of DRB5, DRB1, DQB1 and DRB1*1501 allele
had a higher OR than the DRB1*1501 alone (Table 2).
DRB1*1501 was always in combination with high expression of
DRB5 and DRB1; therefore it was always highly expressed in the
Spanish population. The haplotype formed by the DRB1 and
DQB1 eQTLs, without DRB1*1501 allele, was not associated with
disease, therefore the high expression of this two genes alone did
not contribute to the disease.
Figure 3. Association of the MS-risk variant rs9271100 with DRB1 gene expression levels. In all plots, expression levels are represented for
the three genotype groups. (A) Box plots of expression data from normalized results of ILMN_1715169 (DRB1) probe generated by Illumina Human-6
v2 Expression BeadChip (EMBL-EBI database (http://www.ebi.ac.uk/arrayexpress/) ID projects E-MTAB-198). (B) Box plot of expression data from the
NM_002124 (DRB1) transcript of 41 CEU individuals obtained from RNA-Seq [19]. P-values are calculated by Kruskal Wallis Test.
doi:10.1371/journal.pone.0029819.g003
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The DRB1*1501 allele is always highly expressed in the
different human populations
Since the DRB1*1501 allele was always together with the DRB1
eQTL in the Spanish population, we could not determine the
contribution to MS of the DRB1*1501 allele in low expression
conditions. To try to clarify this question we analyzed the
association of these two variants in African American population
which has a different LD in the region [7]. From the fine mapping
of the HLA region performed by McElroy et al. [7] with 500
African Americans MS patients and 500 healthy controls, we
obtained the genotype of the DRB1*1501 allele and the rs9270986
SNP, which in addition to the DRB5 was eQTL for DRB1 in all
human populations (Table S1). We observed, as in the Spanish
population, that the haplotype formed by the DRB1*1501 and the
allele that correlated with high levels of expression of DRB1 had a
higher OR than the DRB1*1501 alone (Tables 1 and 2). However,
the DRB1*1501, as in the Spanish population, was always in the
same haplotype than the eQTL for DRB1 and DRB5, making
impossible distinguish the effect of the DRB1*1501 alone in this
population as well (Table 2).
We investigated in other human populations if the DRB1*1501
and the eQTL for DRB1 were also in the same haplotype as the
Figure 4. Association of risk-variants for different immune-related diseases with expression levels of HLA genes. Expression data are
from CEU individuals obtained from RNA-Seq [9]. The data are from the transcripts DQB1 NM_002123, DQA1 NM_002122, DRB1 NM_002124, DQA2
NM_020056 and DRB5 NM_002125. Underlined are marked the risk alleles.
doi:10.1371/journal.pone.0029819.g004
Table 1. Conditional logistic regression analysis of the MS associated variants.
Conditional on
Unconditional rs3135388
Spanish SNP Risk allele F_A F_U P OR P cond OR
eQTL DRB5 rs9270986 A 0.2451 0.1256 1.05E-22 2.392 0.117 1.396
eQTL DRB1 rs9271100 T 0.3481 0.2279 1.24E-17 1.881 0.01306 1.275
DRB1*1501 rs3135388 G 0.219 0.1031 1.96E-23 2.591 NA NA
eQTL DQB1 rs9272346 G 0.4455 0.3917 0.0003381 1.265 0.356 0.9341
African Americans
rs9270986 A 0.2154 0.1898 0.15 1.173 0.74 1.043
DRB1*1501 + 0.05705 0.03543 0.022 1.67 NA NA
F_A, Frequency of affected; F_U, Frequency of unaffected; NA, not applicable; P cond, P-value of logistic regression analysis conditioned on the respective SNP; OR, odds
ratio; SNP, single-nucleotide polymorphism. The data from African American are from McElroy et al. [7].
doi:10.1371/journal.pone.0029819.t001
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one observed in the Spanish and the African American popu-
lations. For this end, we analyzed the haplotypes formed by the tag
for DRB1*1501 and the rs9271100, eQTL for DRB1 gene, in
CHB, JPT and CEU populations. We observed that the T allele of
rs9271100, associated with high expression of DRB1 gene, was
always together with DRB1*1501 (Figure S1).
The most associated variants with other
immunopathologies were also eQTLs for different HLA
Class II gene combinations
We decided to analyze whether the correlation between the
expression of HLA Class II genes and HLA associated variants was
specific for MS or could be extended to other autoimmune
diseases. We obtained the GWAS results of several autoimmune
and immune-related diseases in which a disease association with
the Class II locus polymorphisms had been observed. We selected
type 1 diabetes (T1D) [33], inflammatory bowel disease (IBD)
[34], ulcerative colitis (UC) [35,36], systemic lupus erythematosus
(SLE) [37], rheumatoid arthritis (RA) [38], asthma [39] and IgA
deficiency [40]. We analyzed the eQTLs for all HLA genes
described by Mongomery et al. [24] with significance at 0.0001 PT
with respect to the most associated SNP with the different diseases.
In Table 3 we show the eQTLs that correlated with the SNPs
indicating the specific transcript for which the correlation is
strongest. We did not find any transcript of the RNA-Seq data that
correlated with the most associated SNP with RA. Nonetheless, for
the other diseases we found strong correlation with different
combinations of genes of the HLA region. Figure 4 shows the
expression of the different HLA genes with respect to the
genotypes of the most associated variant for each disease. The
associated allele correlated with higher expression of DQB1 and
DQA1 for IBD, DQB1 and DQA1 for UC (Figure 4C, 4D) and
DRB1 for SLE as observed in MS. The other risk alleles for the
diseases described in this work correlated with low levels of
different genes (Figure 4B). The rs9271100 variant was described
as associated with SLE in a Chinese Han population [37].
Although we did not have RNA-Seq data for this population,
Figure 3 shows that TT carriers, homozygous for the risk allele,
expressed higher levels of the DRB1 gene in CHB population with
microarray results. We observed that the variants associated with
UC and IBD, as well as with MS and IgA deficiency, were in high
LD, indicating a common origin (Figure 5). In MS and IgA
deficiency, the susceptibility variants were in total LD. However,
the risk allele in MS is associated with high expression while for
IgA deficiency the risk allele is associated with low expression.
Discussion
Our results indicate that the SNPs that have been extensively
determined to be the main MS association signals, in the HLA
Class II region, correlate with higher expression levels of DRB5,
DRB1 and DQB1 genes. However, the association studies in MS
Spanish and African American cohorts reveal that only changes in
expression levels of these genes are not enough to explain the
association. On the other hand, in all populations studied, due to
LD, the DRB1*1501 allele correlate with higher expression of the
DRB1 gene. These data suggest that the high expression together
with the structural characteristics of the DRB1*1501 receptor are,
therefore, the real cause of MS association.
It has been shown that the immunological synapse strength in the
interaction between the antigen–presenting cells (APC) and the T
cell determine the fate into Th1 or Th2 type T cell [41]. The
stronger TCR signal favor Th1 differentiation and this is dependent
on the potency of TCR/peptide-MHC interactions, density of
peptide-MHC complexes including co-stimulatory molecules and
the duration of T cell-APC contacts. The high expression of Class II
genes could affect directly to the concentration of peptide-MHC
complex. In turn, a specific DRB1 structure could affect on the
duration and specificity of the interaction. Therefore, we propose
that the higher o lower expression of the different HLA molecules
open a spectrum of possible combinations with specific structure
receptors and levels of co-stimulatory molecules that would
determine the magnitude and quality of the T cell response, and
the type of fate decision made by peripheral T cells. In fact, it has
recently been determined by GWAS [30,42] that polymorphisms
close to co-stimulatory molecules such as CD40, CD86 and CD80
are also associated with MS.
In other autoimmune diseases, most of specific associated
variants have in common that they are eQTLs for HLA genes. It is
tentative to speculate that disease susceptibility lies in different
combination of structural variants and gene level expression.
It is interesting to observe that in T1D the risk allele is associated
with low DR and DQ genes expression but with high expression in
MS, IBD, UC and SLE. It has been speculated that low levels of
HLA molecules in the cortical thymic epithelial cells during thymic
Table 2. Association with MS of the haplotypes bearing the DRB1*1501 SNPs and the eQTLs for DRB5, DRB1 and DQB1 genes.
Population Haplotypes F_A F_U OR P
Spanish rs9270986 rs9271100 rs3135388 rs9272346
A (.) DRB5 T (.) DRB1 G DRB1*1501+ G (.) DQB1 0.2126 0.09729 2.67 1.93E-23
C (,) DRB5 T (.) DRB1 A DRB1*15012 G (.) DQB1 0.1002 0.0977 1.03 0.777
C (,) DRB5 C (,) DRB1 A DRB1*15012 G (.) DQB1 0.1195 0.1894 0.577 1.38E-09
C (,) DRB5 C (,) DRB1 A DRB1*15012 A (,) DQB1 0.545 0.5984 0.799 0.000626
African American rs9270986 DRB1*1501
A (.) DRB1 DRB1*1501+ 0.05705 0.03357 1.77 0.0124
A (.) DRB1 DRB1*15012 0.1587 0.1567 1.02 0.891
C (,) DRB1 DRB1*15012 0.7842 0.8098 0.859 0.177
F_A, Frequency of affected; F_U Frequency of unaffected; OR , Odds Ratio; P, P-value of logistic regression analysis. Only haplotypes with higher frequency than 0.05 are
shown. (.) stands for higher expression; (,) stands for lower expression. Data from African American are from McElroy et al. [7]. Haplotypes for African American are
from rs9270986 (eQTL for DRB5 and DRB1 at the same time) and DRB1*1501.
doi:10.1371/journal.pone.0029819.t002
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clonal deletion will generate a repertoire with increased self-reactivity
T cells which in turn could contribute to the development of T cell-
mediated autoimmunity [4]. The level of clonal deletion of
autoreactive thymocytes is proportional to the concentration of
MHC-self-antigen complexes in the thymus, which will depend on the
levels of expression of the antigens and MHC receptors in the thymus.
One potential limitation of this study is regarding the complex
nature of HLA, which is highly polimorphic and of repetitive
nature. So, expression levels based on hybridization signals might
yield false or spurious associations. This situation could be the case
of some data of this study. However, to overcome this limitation,
we analysed and reproduced array data with the data from RNA-
Seq which is no based on hybridization specificity.
In conclusion, this work opens up a new understanding of the
HLA disease associated variants in which the levels of expression
of the DR and DQ could complement the structural properties for
antigen presentation receptors. This would create additional levels
of diversity and complexity when searching for the causal variants
of the disease association in the HLA region.
Materials and Methods
Genotypes and gene expression data
We analyzed genotype and expression data from 689
unrelated individuals studied by the International HapMap
project [26]. We used the HapMap Phase III genotype data,
release #27. For DRB1 gene expression, we used gene
expression levels for the ILMN_1715169 probe that had been
measured previously in lymphoblastoid cell lines from all 689
unrelated individuals using Array design A-MEXP-930 -
Illumina Human-6 v2 Expression BeadChip [23]. We down-
loaded the data from EMBL-EBI database (http://www.ebi.ac.
uk/arrayexpress/) ID projects E-MTAB-198 and E-MTAB-
264. Data from RNA-Seq for DRB1 (NM_002124), DRB5
(NM_002125) and DQB1(NM_002123), DQA1 (NM_002122),
DQA2 (NM_020056) from 41 lymphoblastoid cell lines from
CEU HapMap samples were generated by Cheung et al. and
downloaded from (http://www.ebi.ac.uk/arrayexpress/) ID
projects E-GEOD-16921 [19]. Data for eQTLs generated from
60 HapMap individuals of European descent were generated by
Montgomery et al. [24] and downloaded from http://jungle.
unige.ch/rnaseq_CEU60/.
Expression association analysis and multiple test
correction
We used Spearman’s correlation to test for associations in cis
between SNP genotypes and probe expression levels in each
population. This method has been previously shown to produce
robust results and avoids the effect of outliers in gene expression
values [27]. We analyzed the SNPs from HapMap included
Table 3. Most associated HLA variants of different diseases and correlation with expression levels of HLA Class II genes.
Disease SNP GWAS [ref.] Gene Transcripts r Value p Value
Risk
Allele
Risk Allele
Frequency
UC rs9268853 [35] DQA2 ENST00000374940 0.728 4.33E-11 T 0.66
DQB1 ENST00000399074 20.637 4.41E-08
rs2395185 [36] DQA2 ENST00000374940 0.728 4.33E-11 G 0.61
DQB1 ENST00000399084 20.637 4.41E-08
IBD rs477515 [34] DQB1 ENST00000399082 0.591 6.50E-07 G 0.69
DQA1 ENST00000374940 20.708 2.41E-10
T1D rs9272346 [33] DQB1 ENST00000399082 0.629 7.30E-08 G 0.61
DQB1 ENST00000399074 0.809 6.00E-15
DQB1 ENST00000399084 0.85 ,E-15
DQA1 ENST00000395364 0.803 1.20E-14
DQA1 ENST00000343139 0.769 7.27E-13
SLE rs9271100 [37] DRB1 ENST00000360004 0.731 3.22E-11 T 0.14
DQB1 ENST00000399084 0.621 1.17E-07
MS rs3135388 [29] DQB1 ENST00000399065 20.647 2.34E-08 A 0.22
DRB5 ENST00000374975 20.728 4.40E-11
DRB1 ENST00000360004 20.702 3.98E-10
IgA deficiency rs9271366 [40] DQB1 ENST00000399065 0.647 2.34E-08 A 0.85
DRB5 ENST00000374975 0.728 4.40E-11
DRB1 ENST00000360004 0.702 3.98E-10
Asthma rs9272346 [39] DQB1 ENST00000399082 0.629 7.30E-08 G 0.61
DQB1 ENST00000399074 0.809 6.00E-15
DQB1 ENST00000399084 0.85 ,E-15
DQA1 ENST00000395364 0.803 1.20E-14
DQA1 ENST00000343139 0.769 7.27E-13
Diseases: Type 1 diabetes (T1D), inflammatory bowel disease (IBD), ulcerative colitis (UC), systemic lupus erythematosus (SLE), asthma, IgA deficiency and multiple
sclerosis (MS). SNP GWAS indicate the most associated variant detected by GWAS, references in brackets. Transcripts are with Ensembl nomenclature. r values
(correlation coefficient) and p-values from Spearman correlation test.
doi:10.1371/journal.pone.0029819.t003
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between 29677984 to 33485635 of chromosome 6 (Build 36].
Significance thresholds for each gene were assigned after 10,000
permutations of expression values relative to genotypes. Compu-
tation of the Spearman correlation test has been performed with
Genetranssoc (http://bios.ugr.es/Genetranassoc/), a c++ software
with an analogous implementation of the Spearman coefficient in
the statistical package R which also computes statistical signifi-
cance using permutation tests.
Study subjects
Case samples comprised 1049 Caucasian individuals with
clinically defined MS according to Poser’s criteria [43]. These
samples were obtained from four public hospitals: the Hospital
Clı´nico in Granada (n = 106), the Hospital Virgen de las Nieves
in Granada (n = 145), the Hospital Carlos Haya in Ma´laga
(n = 622) and the Hospital Virgen de la Macarena in Seville
(n = 176). All three cities are within a 200 km radius in the South
of Spain. The mean age of the individuals at case sample
collection was 36 years and the mean age of controls at interview
was 38 years. The percentage of females was 68% for cases and
68% for controls. All cases were classified as having RR
(relapsing-remitting) or SP (secondary progressive) forms of MS.
Controls were 972 blood donors with no history of inflammatory
disease attending the blood banks. The study was approved by
the Ethics Committees of Hospital Virgen Macarena, Sevilla,
Hospital Virgen de las Nieves, Granada and Hospital Carlos
Haya, Malaga, and written informed consent was obtained from
all participants.
SNPs Genotyping
rs3135388, rs9271100, rs9270986, rs9272346 were genotyped
using TaqmanH SNP Genotyping Assays (Applied Biosystems)
methodology according to the manufacturer’s specifications.
Data management and statistical analysis
Association testing, Hardy–Weinberg Equilibrium, conditional
logistic regression analyses, and haplotype analyses were carried
out using PLINK version 1.07 [44]. Linkage disequilibrium
patterns between SNPs were analyzed with Haploview 4.2 [45].
The Kruskal-Wallis test was performed with SPSS software.
Supporting Information
Figure S1 Haplotype formed by the tag for DRB1*1501
and the rs9271100, eQTL for DRB1 gene, in CHB, JPT
and CEU populations. The LD plots and haplotypes are
obtained from the HapMap data of the different populations. The
DRB1*1501 allele is tagged by different allele combinations in each
population as reported by Gregersen et al. (6). The Tags for
DRB1*1501 are: CEU, rs3135388 G; CHB, rs7773756 T , rs6903608
C, rs620202 G; JPT, rs7773756 T, rs6919855 C, rs6901830 G.
(PDF)
Table S1 Spearman correlation test of variants associ-
ated with DRB1 expression in different human popula-
tions.
(XLSX)
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